165 related articles for article (PubMed ID: 33306856)
1. Anti-FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer.
Kobayashi S; Hiwasa T; Ishige T; Kano M; Hoshino T; Rahmutulla B; Seimiya M; Shimada H; Nomura F; Matsubara H; Matsushita K
Cancer Sci; 2021 Feb; 112(2):847-858. PubMed ID: 33306856
[TBL] [Abstract][Full Text] [Related]
2. Anti-FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma.
Kobayashi S; Hiwasa T; Ishige T; Rahmutulla B; Kano M; Hoshino T; Minamoto T; Shimada H; Nomura F; Matsubara H; Matsushita K
Cancer Sci; 2019 Jun; 110(6):2004-2013. PubMed ID: 30980774
[TBL] [Abstract][Full Text] [Related]
3. Combinational antibody detection approach increases the clinical validity of colorectal cancer screening.
Kobayashi S; Hiwasa T; Kitamura K; Kano M; Hoshino T; Hirano S; Hashimoto M; Seimiya M; Shimada H; Nomura F; Matsubara H; Matsushita K
J Clin Lab Anal; 2023 Nov; 37(21-22):e24978. PubMed ID: 37964630
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
[TBL] [Abstract][Full Text] [Related]
5. Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients.
Kobayashi S; Hoshino T; Hiwasa T; Satoh M; Rahmutulla B; Tsuchida S; Komukai Y; Tanaka T; Matsubara H; Shimada H; Nomura F; Matsushita K
Oncotarget; 2016 Dec; 7(50):82493-82503. PubMed ID: 27756887
[TBL] [Abstract][Full Text] [Related]
6. Titration of serum p53 antibodies in patients with gastric cancer: a single-institute study of 40 patients.
Shimizu K; Ueda Y; Yamagishi H
Gastric Cancer; 2005; 8(4):214-9. PubMed ID: 16328595
[TBL] [Abstract][Full Text] [Related]
7. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated autoantibody signature for the early detection of gastric cancer.
Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A
Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer.
Qin J; Wang S; Wang P; Wang X; Ye H; Song C; Dai L; Wang K; Jiang B; Zhang J
J Cancer Res Clin Oncol; 2019 May; 145(5):1253-1262. PubMed ID: 30887154
[TBL] [Abstract][Full Text] [Related]
10. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
11. Serum p53 antibody: useful for detecting gastric cancer but not for predicting prognosis after surgery.
Oshima Y; Suzuki T; Yajima S; Nanami T; Shiratori F; Funahashi K; Shimada H
Surg Today; 2020 Nov; 50(11):1402-1408. PubMed ID: 32458231
[TBL] [Abstract][Full Text] [Related]
12. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
[TBL] [Abstract][Full Text] [Related]
14. Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis.
Hu L; Liu J; Shimada H; Ito M; Sugimoto K; Hiwasa T; Zhou Q; Li J; Shen S; Wang H
Front Oncol; 2022; 12():870086. PubMed ID: 35656505
[TBL] [Abstract][Full Text] [Related]
15. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
16. Stage-Specific Alteration and Prognostic Relationship of Serum Fumarate Hydratase Autoantibodies in Gastric Cancer.
Sasajima N; Sumazaki M; Oshima Y; Ito M; Yajima S; Takizawa H; Wang H; Li SY; Zhang BS; Yoshida Y; Hiwasa T; Shimada H
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791507
[TBL] [Abstract][Full Text] [Related]
17. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
Yin LK; Sun XQ; Mou DZ
Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
[TBL] [Abstract][Full Text] [Related]
18. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer.
Chen C; Chen Q; Zhao Q; Liu M; Guo J
Ann Clin Lab Sci; 2017 May; 47(3):260-263. PubMed ID: 28667025
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Zhang Y; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
